L
Luis Rodrigo
Researcher at University of Oviedo
Publications - 355
Citations - 14395
Luis Rodrigo is an academic researcher from University of Oviedo. The author has contributed to research in topics: Hepatitis C virus & Hepatitis C. The author has an hindex of 58, co-authored 341 publications receiving 12963 citations. Previous affiliations of Luis Rodrigo include Central University, India & Services Hospital.
Papers
More filters
Journal ArticleDOI
Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
Raúl J. Andrade,M. Isabel Lucena,M. Carmen Fernández,G. Pelaez,Ketevan Pachkoria,Elena García-Ruiz,B. García-Muñoz,Rocío González-Grande,Angeles Pizarro,José Antonio Durán,Manuel Jimenez,Luis Rodrigo,Manuel Romero-Gómez,J.M. Navarro,Ramon Planas,Joan Costa,Africa Borras,Aina Soler,Javier Salmerón,Rafael Martín-Vivaldi +19 more
TL;DR: Patients with drug-induced hepatocellular jaundice have 11.7% chance of progressing to death or transplantation, and amoxicillin-clavulanate stands out as the most common drug related to DILI.
Journal ArticleDOI
Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
Basilio Soto,Armando Sánchez-Quijano,Luis Rodrigo,Juan A. del Olmo,Manuel García-Bengoechea,José Hernández-Quero,C. Rey,M. A. Abad,Manuel S. Rodriguez,María Sales Gilabert,Francisco Javier Esandi Gonzalez,P. Mirón,Antonio Caruz,Federico Relimpio,R. Torronteras,Manuel Leal,Eduardo Lissen +16 more
TL;DR: HIV-related immunodeficiency may be a determinant of higher hepatitis C viremia levels and more severe liver damage and mean interval from estimated time of HCV infection to cirrhosis was significantly longer in HIV-negative than HIV-positive patients.
Journal ArticleDOI
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
Angel Lanas,Luis A García-Rodríguez,Mónica Polo-Tomás,Marta Ponce,Inmaculada Alonso-Abreu,Maria Ángeles Pérez-Aisa,Javier Perez-Gisbert,Luis Bujanda,Manuel J. Castro,María Jesús Muñoz,Luis Rodrigo,Xavier Calvet,Dolores Del-Pino,Santiago García +13 more
TL;DR: Over the past decade, there has been a progressive change in the overall picture of GI events leading to hospitalization, with a clear decreasing trend in upper GI events and a significant increase in lower GI events, causing the rates of these two GI complications to converge.
Journal ArticleDOI
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
Angel Lanas,Luis A García-Rodríguez,María Teresa Arroyo,Fernando Gomollón,Faust Feu,Antonio González-Pérez,E Zapata,G Bástida,Luis Rodrigo,Santos Santolaria,M Güell,C M de Argila,Enrique Quintero,Fernando Borda,J M Piqué +14 more
TL;DR: Coxib use presents a lower RR of UGIB than non-selective NSAIDs, however, when combined with low-dose aspirin, the differences between non-selection NSAIDs and coxibs tend to disappear.
Journal ArticleDOI
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
Rosario F. Velázquez,Manuel Rodriguez,Carmen A. Navascués,A. Linares,Ramón Pérez Pérez,Nieves G. Sotorríos,Isabel Martínez,Luis Rodrigo +7 more
TL;DR: A simple score made up of 4 clinical and biological variables allowed us to distinguish 2 groups of cirrhotic patients at high and low risk for the development of HCC, and it is believed this score can be useful in establishing a subset of cir rhotic patients in whom a surveillance program for early detection of H CC could be unjustified.